Concepedia

Single- and repeated-dose toxicity study of bevacizumab, ranibizumab, and aflibercept in ARPE-19 cells under normal and oxidative stress conditions

Manuel Sáenz-de-Viteri, Patricia Fernández‐Robredo, María Hernández, Jaione Bezunartea, Nicholas Reiter, Sergio Recalde, Alfredo García‐Layana

Biochemical Pharmacology · 2016 · 24 citations · 31 references

DOI

Concepts

References

31

Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration

New England Journal of Medicine · 2011 · 2.6K citations · Full text

, , +12

Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration

Daniel Martín, Maureen G. Maguire, Stuart L. Fine et al. · Ophthalmology · 2012 · 1.7K citations · Full text

, , +12

Long-term Outcomes of Ranibizumab Therapy for Diabetic Macular Edema: The 36-Month Results from Two Phase III Trials

David M. Brown, Quan Dong Nguyen, Dennis M. Marcus et al. · Ophthalmology · 2013 · 821 citations · Full text

, , +17

Intravitreal Aflibercept Injection for Neovascular Age-related Macular Degeneration

Ursula Schmidt‐Erfurth, Peter K. Kaiser, Jean‐François Korobelnik et al. · Ophthalmology · 2013 · 811 citations

, , +14

Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial

Usha Chakravarthy, Simon Harding, Chris Rogers et al. · The Lancet · 2013 · 753 citations · Full text

, , +15